Silverbirch North Collaborative Health – Trademark Portfolio
Entity Type: 16
Silverbirch North Collaborative Health holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include CEDARVIEW HEALTH. The owner is based in Philadelphia, PA.
709 N 2nd St.Suite 400 #1217
Philadelphia, PA 19123
Showing of trademarks Trademarks
Trademark Classifications
Silverbirch North Collaborative Health's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does Silverbirch North Collaborative Health have?
Silverbirch North Collaborative Health has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Silverbirch North Collaborative Health file in?
Silverbirch North Collaborative Health files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Silverbirch North Collaborative Health's most well-known trademarks?
Silverbirch North Collaborative Health's registered trademark portfolio includes well-known marks such as CEDARVIEW HEALTH. These are among 1 currently registered trademark in the portfolio.
What is Silverbirch North Collaborative Health's trademark registration success rate?
Silverbirch North Collaborative Health has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.